Achilles therapeutics to present at upcoming investor conferences

London, sept. 02, 2021 (globe newswire) -- achilles therapeutics plc (nasdaq: achl), a clinical-stage biopharmaceutical company developing precision t cell therapies to treat solid tumors, today announced that management will present at the following investor conferences in september.
ACHL Ratings Summary
ACHL Quant Ranking